What the Study Found
Scientists have long searched for what goes wrong in the brains of people with schizophrenia. Now, researchers at the Lieber Institute for Brain Development in Baltimore may have found an unexpected piece of the puzzle — in one of the brain’s smallest and least-studied regions, called the habenula.
The habenula is no bigger than a grain of rice. But despite its size, it acts like a command center that helps control how the brain processes reward, motivation, and mood — the very things that often malfunction in mental illness.
“It’s a tiny structure with a huge influence,” said Dr. Kristen Maynard, one of the study’s lead researchers. “And until now, we really didn’t know what was going on inside it.”
Using brain tissue generously donated by families of people who lived with schizophrenia, the Lieber team created the first detailed “cell map” of the human habenula. They found that this miniature brain region contains a surprising diversity of cell types — each with its own genetic fingerprint and specialized role.
When they compared tissue from people with schizophrenia to those without the disorder, they found more than 170 genes that behaved differently. Many of these genes are involved in how brain cells communicate using chemicals like dopamine and serotonin, which are already known to play major roles in mood and perception.
The researchers also discovered specific genetic variations that may explain why some people are more vulnerable to schizophrenia in the first place. Several of these genetic changes were unique to the habenula, meaning they don’t show up in other parts of the brain typically studied in mental illness — such as the prefrontal cortex or hippocampus.
“This could change how we think about schizophrenia, instead of looking only at the big, obvious brain regions, we’re finding that small, specialized hubs like the habenula might be where some of the earliest disruptions occur.”
Why This Matters
Schizophrenia affects millions worldwide and can cause hallucinations, disorganized thinking, and emotional withdrawal. Current treatments mainly target dopamine receptors, but they often work only partially — or not at all — for many patients.
The new findings suggest that the habenula, with its deep connections to both dopamine and serotonin systems, could be a new target for treatments that restore balance to the brain’s emotional circuitry.
What Comes Next
By illuminating the habenula’s genetic blueprint, scientists now have a roadmap for exploring new ways to diagnose, prevent, and treat serious mental illnesses. Future research could help explain why nicotine — which acts on some of the same habenula pathways — temporarily improves symptoms in some people with schizophrenia, and whether drugs targeting this region might bring lasting relief.
In other words, a structure no bigger than a pinhead may hold big answers to one of psychiatry’s oldest mysteries.
You may be interested in
If you want to understand the research from a scientific perspective, we’ve prepared a more detailed summary that outlines our approach and key findings in greater depth.
Dr. Maynard leads a Lieber Institute for Brain Development’s laboratory focused on exploring gene expression, brain structure, and brain function in relation to psychiatric diseases. Learn more about her work and the power of high school teachers to spark interest and passion in brain research.